title: The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats.
abstract: Sodium pentosan polysulfate (SPP), a semi-synthetic glycosaminoglycan, was administered to rats with hyperoxaluria, induced by a vitamin B6 deficient diet, as a model of calcium oxalate stone formation. We studied the preventive effects of SPP on stone formation as well as its inhibitory effects on stone growth by autoradiography and radioluminography after intravenous injection of (14)C-oxalate. The rats were divided into non-treated and SPP-treated groups. The non-treated rats were divided into three groups: one group was fed a regular diet, while the other two groups were fed a vitamin B6 deficient diet for 2 and 4 weeks, respectively. The SPP-treated rats were divided into two groups: one group was intravenously injected with SPP from the start of the vitamin B6 deficient diet for a total of 4 weeks and the other group was injected with the same amount of SPP after 2 weeks of the diet for 2 weeks. (14)C-oxalate renal macroautoradiograms were prepared, and calcium oxalate deposits in the renal tissues were compared between the non-treated and SPP-treated groups. The preventive effects on calcium oxalate stone formation were clearly observed in the group injected with SPP for 4 weeks. Even in the other SPP-treated group, in which the administration of SPP was started at 2 weeks after the start of the diet when calcium oxalate stone formation was already observed, the size of the calcium oxalate deposits observed after 4 weeks was smaller than that in the non-treated group fed a vitamin B6 deficient diet for 4 weeks. In conclusion, our results show that SPP has not only preventive effects on calcium oxalate stone formation but also growth inhibitory effects on stones in hyperoxaluric rats.
authors.affiliation: Department of Urology, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. nakatani@msic.med.osaka-cu.ac.jp
authors.forename: Tatsuya
authors.initials: T
authors.lastname: Nakatani
authors.forename: Keiichi
authors.initials: K
authors.lastname: Ishii
authors.forename: Yukio
authors.initials: Y
authors.lastname: Yoneda
authors.forename: Sadanori
authors.initials: S
authors.lastname: Kamikawa
authors.forename: Toshinao
authors.initials: T
authors.lastname: Kanazawa
authors.forename: Toshikado
authors.initials: T
authors.lastname: Sugimoto
authors.forename: Hartmut
authors.initials: H
authors.lastname: Osswald
mesh_terms: D000818:Animals; D001345:Autoradiography; D002118:Calcium / Q000652:urine; D002129:Calcium Oxalate / Q000378:metabolism / Q000652:urine; D006959:Hyperoxaluria / Q000188:drug therapy* / Q000503:physiopathology; D007668:Kidney / Q000503:physiopathology; D007669:Kidney Calculi / Q000517:prevention & control*; D007679:Kidney Medulla / Q000378:metabolism; D008297:Male; D010426:Pentosan Sulfuric Polyester / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution
chemical_list: D002129:Calcium Oxalate; D010426:Pentosan Sulfuric Polyester; D002118:Calcium